Bausch Health
BHC
#3923
Rank
A$4.86 B
Marketcap
A$13.00
Share price
3.07%
Change (1 day)
36.90%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): A-$3.30

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is A-$3.38. In 2025 the company made an earnings per share (EPS) of A$0.63 an increase over its 2024 EPS that were of A-$0.18.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$3.30-627.63%
2025A$0.63-450%
2024A-$0.18-92.59%
2023A-$2.41160.89%
2022A-$0.92-76.64%
2021A-$3.9668.45%
2020A-$2.35-68.91%
2019A-$7.56-57.11%
2018A-$17.62-272.22%
2017A$10.23-199.29%
2016A-$10.30798.7%
2015A-$1.15-128.31%
2014A$4.05-204.62%
2013A-$3.87602.7%
2012A-$0.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.28-91.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.41-58.15%๐Ÿ‡บ๐Ÿ‡ธ USA